2025 · 2nd Quarter (Apr 1 - June 30)

ELEKTA, INC.

Filed by ELEKTA, INC..

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 22, 2025
Income: Not reported
Expenses: $30,000.00
Registrant: ELEKTA, INC.
Client: ELEKTA, INC.
Filing UUID: b954ced1-ff00-45a4-afda-ab194abc2328
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Medicare Reimbursement and general Medicaid issues.

HCR · Health Issues

Radiation Oncology, Radiation Therapy, Oncology issues, ROCR Value Based Program Act of 2025, H.R. 2120/S. 1031

Literal federal measure citations: H.R. 2120, S. 1031

TRD · Trade (domestic/foreign)

Trade issues between the U.S. and EU, US and China and U.S. - UK

TAR · Tariff (miscellaneous tariff bills)

Tariffs policies between US - EU, US - UK and US - China

ENG · Energy/Nuclear

Nuclear Security issues, Nuclear Health issues, Cobalt 60

BUD · Budget/Appropriations

Labor-HHS and AG-FDA appropriations bills

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.